eCritCare Podcast Swapnil Pawar

Different Vaccines were developed during the COVID-19 pandemic at unprecedented speed using different platforms. However, recent reports raised concerns regarding thrombotic complications and thrombocytopenia after certain vaccines. In this episode, we discuss the pathophysiology and the treatment of this newly described syndrome.

In this episode, we discuss another landmark trial that has answered the very relevant question regarding the use of anti-fibrinolytic treatment in subarachnoid hemorrhage.

The use of neuromuscular blockade is not uncommon however, it's associated with many complications such as the increased risk of ICU acquired weakness, prolonged length of ICU stay along with the increased risk of corneal ulceration and VTE. In this episode, we discuss various indications for the use of NMB agents in ICU and review the available evidence on this topic.

Restrictive Vs Liberal transfusion strategy debate has come to the surface after the publication of the REALITY trial. In this podcast, we dive deeper into proposed transfusion thresholds in intensive care in various subgroups and the evidence behind them. 

Hemoglobin targets in patients with myocardial infarction are still debatable. In this episode, we discuss the landmark REALITY trial, which explores the non-inferiority of a restrictive transfusion strategy over a liberal transfusion strategy.

In this episode, we discuss recently published practice-changing trials RECOVERY and REMAP-CAP. These trials have clearly demonstrated the difference in mortality with the use of Tocilizumab in severe COVID-19.